1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.

KPRX
Kiora Pharmaceuticals, Inc.US flagNASDAQ Capital Market
2.68
USD
-0.04
- -
11.88MMarket Cap

Income Statement (USD)

APIChat
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
1
- -
2
3
- -
- -
- -
- -
16
- -
+ Sales & Services Revenue
- -
- -
- -
- -
1
- -
2
3
- -
- -
- -
- -
16
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
-1
- -
-2
-3
- -
- -
- -
- -
-16
- -
- Operating Expenses
6
3
2
7
14
15
12
10
8
11
12
9
10
9
+ Selling, General & Admin
3
2
2
4
6
5
4
4
5
5
8
5
6
6
+ Research & Development
3
1
1
3
8
10
8
5
4
5
3
4
5
4
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-6
-3
-2
-7
-13
-15
-11
-7
-8
-11
-12
-9
6
-9
- Non-Operating (Income) Loss
- -
1
-1
2
- -
- -
- -
- -
-1
3
2
4
- -
3
+ Interest Expense, Net
- -
1
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
+ Interest Expense
- -
1
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
+ Other Non-Op (Income) Loss
- -
- -
-1
- -
- -
- -
- -
- -
-1
3
2
4
1
4
Pretax Income
-6
-4
-2
-8
-13
-15
-11
-7
-7
-14
-14
-12
6
-12
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
2
-1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-6
-4
-2
-8
-13
-13
-11
-7
-7
-14
-14
-13
4
-11
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-6
-4
-2
-8
-13
-13
-11
-7
-7
-14
-14
-13
4
-11
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-6
-4
-2
-8
-13
-13
-11
-7
-7
-14
-14
-13
4
-11
- Preferred Dividends
- -
- -
- -
8
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-6
-4
-2
-17
-13
-13
-11
-7
-7
-14
-14
-13
4
-11
EBIT
-6
-3
-2
-7
-13
-15
-11
-7
-8
-11
-12
-9
6
-9
EBITDA
-6
-3
-2
-7
-13
-15
-11
-7
-8
-11
-12
-9
6
-9
EBITDA Margin (%)
- -
- -
- -
- -
-1,993.5
-3,567.93
-653.92
-262.75
-67,827.81
- -
- -
- -
35
- -
EBITA
-6
-3
-2
-7
-13
-15
-11
-7
-8
-11
-12
-9
6
-9
Gross Margin (%)
- -
- -
- -
- -
100
100
100
100
100
- -
- -
- -
100
- -
Operating Margin (%)
- -
- -
- -
- -
-1,994.27
-3,572.66
-656.25
-264.67
-68,104.78
- -
- -
- -
34.88
- -
Profit Margin (%)
- -
- -
- -
- -
-1,993.76
-3,243.52
-654.24
-264.21
-56,901.65
- -
- -
- -
22.47
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
4
- -
Basic EPS, GAAP
-4,695.79
-3,019.02
-1,380.54
-14,561.93
-8,161.12
-5,006.79
-1,645.32
-803.16
-538.01
-514.06
-166.94
-23.26
0.93
- -
Basic EPS from Cont Ops
-4,520.13
-2,865.82
-1,207.4
-7,351.42
-8,161.12
-5,006.79
-1,645.32
-803.16
-538.01
-514.06
-166.94
-23.26
0.93
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
4
- -
Diluted EPS, GAAP
-4,695.79
-3,019.02
-1,380.54
-14,561.93
-8,161.12
-5,006.79
-1,645.32
-803.16
-538.01
-514.06
-166.94
-23.26
0.87
- -
Diluted EPS from Cont Ops
-4,520.13
-2,865.82
-1,207.4
-7,351.42
-8,161.12
-5,006.79
-1,645.32
-803.16
-538.01
-514.06
-166.94
-23.26
0.87
- -

Balance Sheet (USD)

APIChat
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
2
1
- -
9
4
8
8
4
2
9
8
5
30
22
+ Cash, Cash Equivalents & STI
2
1
- -
8
4
8
8
4
1
8
6
2
27
17
+ Cash & Cash Equivalents
2
1
- -
8
4
8
8
4
1
8
6
2
4
9
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
23
8
+ Accounts & Notes Receiv
- -
- -
- -
1
- -
- -
- -
- -
- -
1
1
2
1
3
+ Accounts Receivable, Net
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
2
1
3
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
- -
1
- -
1
- -
1
- -
- -
2
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
- -
6
6
6
6
14
11
11
9
7
3
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
- -
6
6
6
6
13
11
11
9
7
2
+ Total Intangible Assets
- -
- -
- -
- -
5
5
6
6
13
11
11
9
7
2
+ Goodwill
- -
- -
- -
- -
- -
2
2
2
4
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
5
4
4
4
10
11
11
9
7
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
2
1
1
10
10
14
14
10
15
20
19
14
36
24
+ Payables & Accruals
1
1
2
1
2
3
1
1
2
1
3
2
6
3
+ Accounts Payable
- -
- -
1
- -
1
1
- -
- -
- -
- -
1
- -
- -
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
- -
1
- -
1
2
1
1
1
1
2
1
3
2
+ ST Debt
- -
2
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
2
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
3
5
12
3
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
2
4
12
3
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
1
3
5
3
7
15
4
1
2
2
3
2
6
4
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
36
36
36
- -
3
1
1
2
3
4
4
6
5
4
+ Accrued Liabilities
- -
- -
- -
- -
2
- -
- -
- -
1
1
1
1
- -
1
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
36
36
36
- -
1
1
1
2
3
3
3
5
4
3
Total Noncurrent Liabilities
36
36
36
- -
3
1
1
2
4
4
4
6
5
4
Total Liabilities
37
39
41
3
10
16
5
3
6
6
7
8
11
8
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
10
10
10
71
78
90
102
107
117
136
146
153
169
171
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
10
10
10
71
78
90
102
107
117
136
146
153
169
170
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-51
-55
-57
-65
-79
-92
-93
-100
-107
-121
-134
-147
-143
-154
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-41
-45
-47
6
- -
-2
9
7
10
15
11
6
26
16
+ Minority/Non Controlling Interest
6
7
7
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-35
-38
-40
6
- -
-2
9
7
10
15
11
6
26
16
Total Liabilities & Equity
2
1
1
10
10
14
14
10
15
20
19
14
36
24
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
3
4
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-2
2
3
-8
-4
-8
-8
-4
-1
-8
-6
-2
-4
-9
Net Debt to Equity
5.57
-3.99
-7.59
-137.91
1,103.52
405.1
-89.57
-57.03
-7.15
-53.88
-52.29
-40.18
-14.72
-53.93
Tangible Common Equity Ratio
-1,486
-5,531.34
-2,845.86
64.02
-134.37
-83.06
37.85
21.67
-186.93
40.71
8.37
-55.21
64.01
63.38
Current Ratio
2.75
0.22
0.04
2.76
0.57
0.57
2.19
3.06
0.87
5.59
2.35
2.9
4.94
5.99
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-6
-4
-2
-8
-13
-13
-11
-7
-7
-14
-14
-13
4
-11
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
-1
3
1
- -
1
2
- -
4
2
5
1
4
+ Stock-Based Compensation
- -
- -
- -
1
1
1
1
1
1
1
- -
1
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
- -
2
2
5
+ Other Non-Cash Adj
- -
1
-1
2
- -
- -
- -
- -
-1
-1
2
2
-1
-1
+ Chg in Non-Cash Work Cap
- -
- -
1
1
4
7
-1
-3
- -
-1
1
-2
4
-3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
-1
3
- -
-1
- -
- -
- -
-1
-1
1
-2
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
+ Inc (Dec) in Accts Payable
- -
- -
1
- -
1
-1
-1
- -
- -
- -
1
-1
4
-2
+ Inc (Dec) in Other
- -
- -
- -
2
- -
8
1
-3
- -
- -
- -
- -
- -
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-5
-3
-1
-4
-8
-6
-11
-8
-7
-11
-10
-10
9
-10
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
14
4
11
10
2
5
18
5
7
15
- -
+ Increase in Capital Stock
- -
- -
- -
14
4
11
10
2
5
18
5
7
15
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-23
15
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
13
23
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-36
-8
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-23
14
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
1
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
1
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-3
+ Other Financing Activities
- -
- -
-1
-1
- -
- -
1
2
- -
- -
3
-1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
1
1
13
3
11
11
4
5
18
9
6
15
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-5
-1
- -
8
-5
4
- -
-4
-3
7
-2
-4
1
5
EBITDA
-6
-3
-2
-7
-13
-15
-11
-7
-8
-11
-12
-9
6
-9
EBITDA Margin (%)
- -
- -
- -
- -
-1,993.5
-3,567.93
-653.92
-262.75
-67,827.81
- -
- -
- -
35
- -
Free Cash Flow
-5
-3
-1
-4
-8
-7
-11
-8
-7
-11
-10
-10
9
-10
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
9
- -
Free Cash Flow to Equity
- -
-1
1
-13
-8
-7
-11
-8
-7
-11
-10
-10
9
-10
Free Cash Flow per Basic Share
-4,063.73
-2,301.65
-739.78
-3,908.12
-5,152.4
-2,464.22
-1,691.45
-922.8
-584.21
-400.9
-128.16
-17.76
2.21
- -
Price/Free Cash Flow
- -
- -
- -
-3.79
-1.71
-2.37
-1.56
-3.91
-3.15
-1.37
-0.24
-0.26
1.59
- -
Cash Flow to Net Income
0.87
0.76
0.54
0.53
0.63
0.49
1
1.15
1.07
0.78
0.77
0.76
2.38
0.92
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -